HENRY S. KINGDON, M.D., Ph.D.; JOSEPH M. BARON, M.D.; GERALD E. BYRNE JR., M.D.; HENRY RAPPAPORT, M.D., F.A.C.P.
Two patients manifested the typical clinical and pathological features of malignant histiocytosis. Objective remissions of 3 months and 2 months, respectively, were induced by combination chemotherapy with vincristine and prednisone. The patients eventually died from complications of this rapidly progressive and uniformly fatal illness without significant prolongation of survival time. Combined chemotherapy may be useful for induction of remission in this disorder, and suitable maintenance programs should be developed.
Learn more about subscription options.
Register Now for a free account.
KINGDON HS, BARON JM, BYRNE GE, RAPPAPORT H. Malignant Histiocytosis: Results of Combination Vincristine-Prednisone Therapy. Ann Intern Med. 1970;72:705–709. doi: 10.7326/0003-4819-72-5-705
Download citation file:
Published: Ann Intern Med. 1970;72(5):705-709.
Hematology/Oncology, Hospital Medicine.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only